ARCTURUS THERAPEUTICS HOLDIN (ARCT)
US03969T1097 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 288.40M | 292.00M | 391.90M | 370.50M | 462.90M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 27.06M | 32.06M | 2.80M | 3.40M | 2.10M | |||
| Other Current Assets | 60.34M | 62.52M | 8.70M | 5.10M | 2.80M | |||
| Total Current Assets | 375.79M | 386.59M | 403.30M | 379.00M | 467.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 41.18M | 40.93M | 45.00M | 11.30M | 8.60M | |||
| Investments And Advances | N/A | N/A | 0.00 | 500.00K | N/A | |||
| Other Non-Current Assets | 1.89M | 1.89M | 2.10M | 2.10M | 100.00K | |||
| Total Non-Current Assets | 43.06M | 42.81M | 47.10M | 13.80M | 8.70M | |||
| TOTAL ASSETS | 418.85M | 429.40M | 450.40M | 392.80M | 476.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 60.70M | 22.50M | 1.30M | |||
| Accrued Expenses | 34.77M | 31.88M | 30.20M | 23.50M | 19.40M | |||
| Accounts Payable | 9.14M | 5.28M | 7.40M | 10.10M | 10.80M | |||
| Other Current Liabilities | 71.52M | 44.83M | 28.60M | 43.50M | 18.10M | |||
| Total Current Liabilities | 115.43M | 81.99M | 127.00M | 99.50M | 49.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 40.60M | 13.80M | |||
| Other Non-Current Liabilities | 39.45M | 68.90M | 53.10M | 24.40M | 16.50M | |||
| Total Non-Current Liabilities | 39.45M | 68.90M | 53.10M | 65.10M | 30.40M | |||
| TOTAL LIABILITIES | 154.88M | 150.89M | 180.10M | 164.60M | 79.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -394.68M | -367.87M | -338.10M | -347.50M | -143.80M | |||
| Additional Paid In Capital | 658.63M | 646.35M | 608.40M | 575.70M | 540.30M | |||
| Common Shares | 27.00K | 27.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 26.92M | 26.83M | 26.60M | 26.40M | 26.20M | |||
| Tangible Book Value per Share | 9.81 | 10.38 | 10.16 | 8.64 | 15.14 | |||
| Total Shareholders' Equity | 263.97M | 278.51M | 270.30M | 228.20M | 396.60M | |||
| TOTAL LIABILITIES AND EQUITY | 418.85M | 429.40M | 450.40M | 392.80M | 476.50M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.18 | 0.03 | |||
| Current Ratio | 3.26 | 4.72 | 3.18 | 3.81 | 9.45 | |||
| Return On Assets (ROA) | -25.62% | -6.92% | 2.06% | -51.86% | -15.13% | |||
| Return On Equity (ROE) | -40.66% | -10.67% | 3.44% | -89.26% | -18.18% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | 2.98% | N/A | N/A | |||
All data in USD